Imad M Tleyjeh (Imad Tleyjeh)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 7

Top Topics

Monoclonal Antibody

Juvenile Idiopathic Arthritis

Coronavirus Disease

Drug Administration

Top Venues

Open forum infectious diseases

Journal of general internal medicine

Clinical pharmacology and therapeutics

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

This page only lists publications with an associated author ORCID identifier.

Publications

Fatemeh Saheb Sharif-Askari, Hawra Ali Hussain Alsayed, Imad M Tleyjeh, Narjes Saheb Sharif-Askari, Ali Al Sayed Hussain, Basema Saddik, Qutayba Hamid, Rabih Halwani
Sotrovimab Lowers the Risk of COVID-19 Related Hospitalization or Death in a Large Population Cohort in the United Arab Emirates. Clinical pharmacology and therapeutics 112 (6) (2022)
Tarek Kashour, Rabih Halwani, Yaseen M Arabi, M Rizwan Sohail, John C O'Horo, Andrew D Badley, Imad M Tleyjeh
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility. Immunopharmacology and immunotoxicology 43 (1) (2021)
Zachary A Yetmar, Supavit Chesdachai, Tarek Kashour, Muhammad Riaz, Danielle J Gerberi, Andrew D Badley, Elie F Berbari, Imad M Tleyjeh
Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Open forum infectious diseases 8 (7) (2021)
Imad M Tleyjeh, Tarek Kashour, Jay Mandrekar, Diana B Petitti
Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician. Open forum infectious diseases 8 (8) (2021)
Imad M Tleyjeh
The Misleading "Pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 72 (12) (2021)
Areej A Malhani, Mushira A Enani, Fatemeh Saheb Sharif-Askari, Mona R Alghareeb, Roaa T Bin-Brikan, Safar A AlShahrani, Rabih Halwani, Imad M Tleyjeh
Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study. PloS one 16 (6) (2021)
Imad M Tleyjeh, Tarek Kashour
Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York City. Journal of general internal medicine 36 (3) (2021)